Clinical Metadata Governance And Trial Suppliers & Manufacturers

GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with ...

Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in people with diabetes. This pre-clinical technology is directed at regulating a hormone in the pancreas called somatostatin which in Type ...

Apollo Neuroscience is pioneering a new category of wearable technology that actively improves health, using touch therapy to promote stress resilience, sleep, focus, recovery, and more. We believe that the human body is powerful, resilient, and has ...

Amgen is one of the world™s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. Amgen is committed to ...

Vivozon is a global innovative drug development company established in 2008. We built an efficacy-based new drug discovery system that is clearly distinct from the existing new drug development paradigm, and discovered the non- narcotic analgesic ...

Our goal is to transform animal health through data intelligence. We will create the first integrated biomarker, health microchip and activity monitor for pets and livestock, for real time remote health monitoring, early detection of disease, ...

Curadigm is an early-stage company focused on shifting the paradigm of therapeutic clearance, bioavailability, and efficacy to improve treatment outcomes for millions of patients. Curadigm was spun-off from Nanobiotix, a late-stage clinical company, ...

Xeltis is a clinical-stage medical device company pioneering a restorative approach in cardiovascular therapy. RestoreX™, Xeltis technology platform, is the world’s first polymer-based technology designed to enable natural restoration of ...

Statsols is the company behind nQuery. nQuery is the complete trial design platform to make clinical trials faster, less costly and more successful. For over 20 years, we have worked with biostatisticians and researchers all over the world to ensure ...

Lorem Cytori is committed to providing meaningful and quality therapeutic options with broad utility that benefit patients and healthcare providers around the world. Whether it’s advancing our product and technology pipeline, performing clinical ...

VetStem Biopharma has endeavored to improve the lives of animals through regenerative medicine. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, VetStem pioneered the use ...

Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of ...

InnovHeart, with locations in Milan, Italy, and Boston, Massachusetts, develops transcatheter mitral valve replacement (TMVR) systems to treat patients suffering from mitral valve disease. The company is currently in clinical trials testing its ...

Geistlich Pharma North America brings the leader in regenerative dentistry directly to the United States and Canada. For 160 years, our respected family-owned Swiss parent company has pioneered technological advances that make regenerative ...

Intelerad provides a range of products and technology to streamline the flow of information across healthcare departments and processes. Leveraging cloud and AI technology, their solutions enable independent reading groups, hospitals, radiology, and ...

Kurve Therapeutics drug delivery technology is designed to target the most difficult part of the treatment process - getting medication through the blood-brain barrier and into the brain. Kurve Therapeutics has 18 peer-reviewed publications of ...

LIXTE is a drug discovery company that has a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100, our lead clinical compound. LB-100 has potential widespread use as an anti-cancer agent when used alone and in ...

At veriNOS Pharmaceuticals, we focus on the clinical development of a drug that specifically inhibits a defined cascade that is relevant and common in different disease settings. The activation of iNOS with subsequent excessive production of cell ...

Founded in 2009, Flagship Biosciences, Inc., is a technology-driven spatial biology and biomarker services company delivering the most accurate and informative data available. We are revolutionizing biomarker analysis to improve drug development and ...

We are leading the way in developing green, enabling biotechnology and nanotechnology drug delivery platforms and enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and ...